Syncom Formulations attracts investor attention on NSE

26 May 2026via simplywall.stSource

English हिंदी తెలుగు தமிழ்ಕನ್ನಡ मराठी বাংলা ગુજરાતી

Syncom Formulations attracts investor attention on NSE due to increased retail interest and positive sentiment. The stock has seen a 15% rise in the past week, outperforming sector benchmarks. Trading volumes surged to 2.3x average, indicating momentum buildup. Fundamentally, it remains a small-cap with moderate revenue growth.

📊 STOCKS: SYNCOMF | 🏢 SECTOR: Pharma | #LOWIMPACT #Pharma

#Pharma#SmallCap#InvestorSentiment

Stocks mentioned

SYNCOMFSyncom Formulations (India) Limited

⚠️ This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.

Trade smarter on NSE

Live option chains, FII flows, PCR, AI analysis — for NIFTY, BANKNIFTY & 200+ F&O stocks.

Start for ₹1 →